Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLIPA trial of Broncho-Vaxom after severe infant bronchiolitis
ACTRN12621001556831Phase 2Active, not recruiting
- Sponsor
- Queensland University of Technology
- Start
- Feb 2022
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in bronchiolitis comparing Broncho-Vaxom with Placebo (2 arms). Primary endpoint: Rate of parent-reported wheeze episodes. Started Feb 2022; status: active, not recruiting.
02
Drugs
OM-85
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on ACTRN12621001556831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001556831.